|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||86.49 - 87.84|
|52 Week Range||44.36 - 87.84|
|Beta (5Y Monthly)||1.13|
|PE Ratio (TTM)||27.51|
|Forward Dividend & Yield||2.11 (2.50%)|
|Ex-Dividend Date||Feb. 04, 2021|
|1y Target Est||98.67|
Siemens increased its full year profit and sales outlook for the second time this year on Friday as the Germany industrial group became the latest company to report a recovery from last year's pandemic-driven downturn. The Munich company said it was seeing strong momentum in the automotive and machine building sectors and for industrial software, helping it to beat forecasts for revenue, orders, and industrial profit during the three months to the end of March. Like other industrial companies such as Switzerland's ABB and France's Schneider Electric Siemens has been seeing increasing orders as customers ramp up their production, and an improvement in China.
BERLIN (Reuters) -German health technology company Siemens Healthineers has raised its full-year sales and profit forecast for the second time this year, as the COVID-19 pandemic continues to drive demand for its rapid antigen tests. Makers of diagnostic tests, including rivals Roche and Becton Dickinson, are benefiting from strong demand for testing as countries try to contain infection waves and rely on testing to start opening up parts of society. Healthineers now expects sales to increase 14% to 17% in the year to September, while adjusted basic earnings per share are forecast at 1.90 euros to 2.05 euros versus an earlier forecast of 1.63 euros to 1.82 euros.
TOTAL (TOT) collaborates with Siemens Energy to reduce emissions related to LNG production. TOTAL's LNG production is likely to increase 10% in 2021 from 2020 levels.